Albumin Contraindications
Albumin is absolutely contraindicated in patients with a history of allergic reactions to albumin, and should be avoided in patients with congestive heart failure, renal insufficiency, and stabilized chronic anemia due to high risk of circulatory overload. 1
Absolute Contraindications
- History of allergic reaction to albumin is a specific contraindication to use 1
- Patients with documented hypersensitivity to albumin products must not receive albumin therapy 1
Relative Contraindications and High-Risk Populations
Cardiac Conditions
- Congestive heart failure represents a special risk for developing circulatory overload with albumin administration 1
- Patients with heart failure and hypoalbuminemia (≤2.9 g/dL) who receive albumin show increased in-hospital mortality and prolonged ICU/hospital stays 2
- Hypoalbuminemia in heart failure patients is independently associated with increased mortality risk, but albumin replacement does not improve outcomes and may worsen them 3, 2
Renal Disease
- Renal insufficiency places patients at special risk of circulatory overload 1
- Patients with acute kidney injury should receive albumin cautiously with careful volume status monitoring 4
Hematologic Conditions
- Stabilized chronic anemia is listed as a condition requiring special caution due to circulatory overload risk 1
Critical Safety Concerns with Albumin Use
Fluid Overload Risk
- Pulmonary edema and fluid overload are significant risks, particularly when targeting specific albumin levels rather than using for defined indications 5
- The ATTIRE trial demonstrated significantly higher rates of pulmonary edema when albumin was used to maintain serum albumin ≥3 g/dL in hospitalized cirrhosis patients 5
- Doses exceeding 87.5 g in spontaneous bacterial peritonitis patients are associated with worse outcomes due to fluid overload 5
Pulmonary Complications
- In cirrhosis patients with sepsis-induced hypotension, 20% albumin showed higher rates of pulmonary complications despite better shock reversal 5
- Albumin should be infused slowly to prevent cardiac overload, especially in patients with preexisting cardiomyopathy 5, 6
Clinical Scenarios Where Albumin Should Be Avoided
Inappropriate Indications
- Nutritional supplementation - albumin should never be used to correct hypoalbuminemia per se without hypovolemia 7
- Routine hypoalbuminemia correction in critically ill patients without specific liver-related indications 7, 8
- Broad resuscitation use in critically ill cirrhosis/ACLF patients is not well-defined and may cause harm 5
Heart Failure Specific
- Albumin administration in heart failure patients with serum albumin ≤2.9 g/dL is associated with increased mortality (p<0.001) 2
- No benefit demonstrated for albumin use in heart failure, only potential harm from volume overload 2
Monitoring Requirements to Prevent Complications
When albumin must be used despite risk factors, implement these safeguards:
- Cardiovascular monitoring: Assess for signs of fluid overload including jugular venous distension, pulmonary edema, and peripheral edema 6
- Respiratory monitoring: Watch for dyspnea, decreased oxygen saturation, and pulmonary crackles 6
- Volume status assessment: Use bedside transthoracic echocardiography to evaluate cardiac preload and function before and during administration 5, 4
- Renal function tracking: Monitor creatinine and urine output closely 6, 4
Common Pitfalls to Avoid
- Do not use albumin to "correct" low albumin levels in critically ill patients without specific indications (large-volume paracentesis >5L, spontaneous bacterial peritonitis, hepatorenal syndrome) 5, 7
- Do not exceed recommended doses - higher doses increase fluid overload risk without additional benefit 5
- Do not use in heart failure patients with hypoalbuminemia expecting benefit - evidence shows harm 2
- Do not infuse rapidly - slow administration is essential to prevent cardiac overload 5, 6
Additional Adverse Effects
Beyond contraindications, albumin can cause: